Volume 100, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Zika virus (ZIKV) has been presumed to be endemic in Southeast Asia (SEA), with a low rate of human infections. Although the first ZIKV evidence was obtained in the 1950s through serosurveys, the first laboratory-confirmed case was only detected in 2010 in Cambodia. The epidemiology of ZIKV in SEA remains uncertain because of the scarcity of available data. From 2016, subsequent to the large outbreaks in the Pacific and Latin America, several Asian countries started reporting increasing numbers of confirmed ZIKV patients, but no global epidemiological assessment is available to date. Here, with the aim of providing information on ZIKV circulation and population immunity, we conducted a seroprevalence study among blood donors in Vientiane, Laos. Sera from 359 asymptomatic consenting adult donors in 2003–2004 and 687 in 2015 were screened for anti-ZIKV IgG using NS1 ELISA assay (Euroimmun, Luebeck, Germany). Positive and equivocal samples were confirmed for anti-ZIKV–neutralizing antibodies by virus neutralization tests. Our findings suggest that ZIKV has been circulating in Vientiane over at least the last decade. Zika virus seroprevalence observed in the studied blood donors was low, 4.5% in 2003–2004 with an increase in 2015 to 9.9% ( = 0.002), possibly reflecting the increase of ZIKV incident cases reported over this period. We did not observe any significant difference in seroprevalence according to gender. With a low herd immunity in the Vientiane population, ZIKV represents a risk for future large-scale outbreaks. Implementation of a nationwide ZIKV surveillance network and epidemiological studies throughout the country is needed.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Dick GWA, Kitchen SF, Haddow AJ, , 1952. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46: 509520. [Google Scholar]
  2. Macnamara FN, , 1954. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 48: 139145. [Google Scholar]
  3. Musso D, Gubler DJ, , 2016. Zika virus. Clin Microbiol Rev 29: 487524. [Google Scholar]
  4. Duffy MR, 2009. Zika virus outbreak on Yap island, Federated States of Micronesia. N Engl J Med 360: 25362543. [Google Scholar]
  5. Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D, , 2017. An update on Zika virus infection. Lancet 390: 20992109. [Google Scholar]
  6. Faria NR, 2016. Zika virus in the Americas: early epidemiological and genetic findings. Science 352: 345349. [Google Scholar]
  7. Pettersson JH-O, 2016. How did Zika virus emerge in the Pacific islands and Latin America? MBio 7: e0123916. [Google Scholar]
  8. WHO, 2016. Zika Situation Report: Zika Virus, Microcephaly and Guillain–Barré Syndrome. Available at: http://apps.who.int/iris/bitstream/10665/204633/1/zikasitrep_17Mar2016_eng.pdf. Accessed November 13, 2017. [Google Scholar]
  9. Marchette NJ, Garcia R, Rudnick A, , 1969. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 18: 411415. [Google Scholar]
  10. Heang V, Yasuda CY, Sovann L, Haddow AD, Travassos da Rosa AP, Tesh RB, Kasper MR, , 2012. Zika virus infection, Cambodia, 2010. Emerg Infect Dis 18: 349351. [Google Scholar]
  11. Plourde AR, Bloch EM, , 2016. A literature review of Zika virus. Emerg Infect Dis 22: 11851192. [Google Scholar]
  12. Lim S-K, Lim JK, Yoon I-K, , 2017. An update on Zika virus in Asia. Infect Chemother 49: 91. [Google Scholar]
  13. Wikan N, Smith DR, , 2017. Zika virus from a southeast Asian perspective. Asian Pac J Trop Med 10: 15. [Google Scholar]
  14. Gallian P, Cabié A, Richard P, Paturel L, Charrel RN, Pastorino B, Leparc-Goffart I, Tiberghien P, de Lamballerie X, , 2017. Zika virus in asymptomatic blood donors in Martinique. Blood 129: 263266. [Google Scholar]
  15. Gake B, Vernet MA, Leparc-Goffart I, Drexler JF, Gould EA, Gallian P, de Lamballerie X, , 2017. Low seroprevalence of Zika virus in Cameroonian blood donors. Braz J Infect Dis 21: 481483. [Google Scholar]
  16. Saba Villarroel PM, 2018. Zika virus epidemiology in Bolivia: a seroprevalence study in volunteer blood donors. PLoS Negl Trop Dis 12: e0006239. [Google Scholar]
  17. Nurtop E, 2018. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virol J 15: 192. [Google Scholar]
  18. Dyer O, , 2016. Zika virus is set to spread through Asia, WHO says. BMJ 355: i5577. [Google Scholar]

Data & Media loading...

Supplemental figure

  • Received : 24 May 2018
  • Accepted : 08 Dec 2018
  • Published online : 28 Jan 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error